Covered recipient · General Payments record
DENISE B PECHT
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecology
General Payments · PY2018–2024
$3,551.67
- Reported across 172 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $256.44 | 14 |
| Education | $13.35 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $77.27 | 4 |
| Exeltis, USA Inc. | $33.20 | 2 |
| MAYNE PHARMA COMMERCIAL LLC | $31.74 | 1 |
| Organon LLC | $31.68 | 3 |
| Hologic Sales and Service, LLC | $25.61 | 1 |
| Exact Sciences Corporation | $20.00 | 1 |
| Sumitomo Pharma America, Inc. | $19.28 | 1 |
| PFIZER INC. | $17.66 | 1 |
| MILLICENT US INC | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $19.10 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139290936 | CMS |
| Astellas Pharma US Inc | $20.06 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139276150 | CMS |
| Astellas Pharma US Inc | $20.06 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139404079 | CMS |
| Astellas Pharma US Inc | $18.05 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139437586 | CMS |
| Exact Sciences Corporation | $20.00 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114829765 | CMS |
| Exeltis, USA Inc. | $14.49 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150001772 | CMS |
| Exeltis, USA Inc. | $18.71 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150001774 | CMS |
| Hologic Sales and Service, LLC | $25.61 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084922994 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $31.74 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154662309 | CMS |
| MILLICENT US INC | $13.35 | 10/30/2024 | Education | Undisputed | 01/23/2026 | 1150910808 | CMS |
| Organon Llc | $3.99 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136211101 | CMS |
| Organon Llc | $18.38 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136211103 | CMS |
| Organon Llc | $9.31 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136211105 | CMS |
| PFIZER INC. | $17.66 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131625477 | CMS |
| Sumitomo Pharma America, Inc. | $19.28 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148902387 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.